Steve Jolley is recognized as an expert in global safety compliance and signal detection, often speaking at prominent industry gatherings such as those hosted by DIA and MHRA.

‍

With 25 years of experience in drug safety and pharmacovigilance, he has collaborated with over 50 clients across the United States, Europe, and Japan. He earned degrees in mathematics and computer science from Cambridge University in England. Steve frequently participates as a featured speaker alongside the FDA at DIA conferences and webinars, focusing on topics like auditing, signaling, and data mining.

‍

Steve’s career in the pharmaceutical industry began in 1985 when he founded DLB Systems, a company that provided computer systems for clinical trials and adverse event reporting to major life science companies globally. After DLB was acquired by eResearch Technologies in 1997, Steve transitioned to working as an independent consultant.